CoronaryAtlas logo
CoronaryAtlas
ASCVD Risk Atlas
← Back to table
C

Alzheimer's disease

Comorbid ConditionsDisease / conditionrisknon modifiable
16
evidence score

Also known as: Alzheimer disease

PREVENT status

Not a PREVENT input variable.

Causal support

trial evidence

Score components
lit volume: 3meta-analyses: 0trials: 12.7genetic: 0MR bonus:

References (1)

0 meta-analyses / systematic reviews

Clinical trials (18)

NCTTitleStatusTypeInterventions
NCT07361887Deciphering the Effect of Moderate Wine Consumption on Healthy Aging Through Postprandial Extracellular VesiclesRECRUITINGINTERVENTIONALWhite Wine, Red Wine, Water
NCT06705010Non-Invasive Monitoring of Brain Metabolites Using Novel and Adapted Proton and Deuterium MR TechniquesNOT YET RECRUITINGINTERVENTIONALApplication of new pulse sequence package SIGNATURES2023 to healthy controls, Application of new pulse sequence package SIGNATURES2023 to 4 groups of patients (pilot)
NCT04795466Exploratory PLatform Trial on Anti-Inflammatory Agents in Alzheimer's Disease (EXPLAIN-AD): A Randomized, Placebo-controlled, Multicenter Platform Study to Evaluate the Efficacy, Safety, Tolerability and Pharmacokinetics of Various Anti-inflammatory Agents in Patients With Mild Cognitive Impairment Due to Alzheimer's Disease and Mild Alzheimer's DiseaseTERMINATEDINTERVENTIONALCanakinumab, Placebo
NCT03683394Multidomain Alzheimers Risk Reduction Study (MARRS) PilotCOMPLETEDINTERVENTIONALSMARRT Intervention, Health Education Intervention
NCT02789800Patient-Centred Innovations for Persons With Multimorbidity - QuebecCOMPLETEDINTERVENTIONALDIMAC02
NCT02707458Dose-finding and Proof-of-concept Trial of Probucol to Increase Availability of CSF Apolipoprotein-ECOMPLETEDINTERVENTIONALProbucol
NCT02742597Patient-Centred Innovations for Persons With Multimorbidity - OntarioCOMPLETEDINTERVENTIONALTIP / IMPACT Plus Care Coordination
NCT02709356Proof of Concepts: Can a Supplement Ketogenic Based MCT Oil Increases Cerebral Capture Ketones in People With Alzheimer's Disease?COMPLETEDINTERVENTIONAL1-month of 60-40 MCT oil, 1-month of C8 MCT oil
NCT02843906Cognitive, Morphological and Neurobiological Progressive Aspects in Bipolar Disorders in the Elderly: Toward to a Neurodegenerescence Detection?UNKNOWNINTERVENTIONALLombar Punction, Magnetic Resonance Imaging (MRI), Positron-Emission Tomography (TEP) /(FDG)
NCT02471833Health Evaluation in African Americans Using RAS TherapyCOMPLETEDINTERVENTIONALTelmisartan 20mg, Telmisartan 40mg, Placebo
NCT01780974Pilot Study: Lipoic Acid and Omega-3 Fatty Acid for Alzheimer's Disease PreventionCOMPLETEDINTERVENTIONALLipoic Acid plus Omega-3 Fatty Acids, Placebo
NCT00597376A Six-month, Double-blind, Placebo-controlled, Single Site Study of Cerefolin NAC on Blood Homocysteine, Oxidative Stress, and Beta-amyloid Biomarkers That May Potentiate Inflammation and Neuronal Damage in Older Individuals With Memory Complaints Who Have Not Been Clinically Diagnosed With Mild Cognitive Impairment, Vascular Dementia, or Alzheimer's DiseaseCOMPLETEDINTERVENTIONALCerefolin NAC (a medical food), Cerefolin NAC placebo
NCT00056225High Dose Supplements to Reduce Homocysteine and Slow the Rate of Cognitive Decline in Alzheimer's Disease (Vitamins to Slow Alzheimer's - VITAL)COMPLETEDINTERVENTIONALFolate, Vitamin B6, Vitamin B12
NCT01211782A Phase 2-3, 6-12 Month, Double-blind, Randomized, Placebo-controlled, Parallel-group Study to Investigate the Effects of Daily Administration of AC-1204 in Subjects With Mild to Moderate Alzheimer's Disease Who Are APOE4(-)WITHDRAWNINTERVENTIONALcaprylic triglyceride, long-chain triglyceride
NCT07600996A Prospective Observational Study of Cerebrospinal Fluid Mitochondrial Biomarkers Measured by Flow Cytometry in Patients With Ischemic Stroke and Alzheimer Disease ControlsRECRUITINGOBSERVATIONALCerebrospinal Fluid Flow Cytometry
NCT03884647DELPHI Software for the Analysis of TMS-EEG Data of Brain Functionality - in Subjects at Risk for Stroke and DementiaCOMPLETEDOBSERVATIONALDELPhI system
NCT02330510Amyloid and Glucose PET Imaging in Alzheimer and Vascular Cognitive Impairment Patients With Significant White Matter DiseaseCOMPLETEDOBSERVATIONAL
NCT01745198Effect of Cerefolin®/CerefolinNAC® on Biomarker Measurements in Patients With Mild Cognitive Impairment, Alzheimer's Disease and Related DisordersCOMPLETEDOBSERVATIONAL

Genetic associations (0)

None linked.